Results 21 to 30 of about 447 (144)

MitraClip for Secondary Mitral Regurgitation

JACC: Case Reports, 2021
We describe the case of an 83-year-old man with a history of ischemic cardiomyopathy and severe secondary mitral regurgitation. This case highlights the role of transcatheter edge-to-edge repair with the MitraClip in the management of symptomatic ...
Brian D. McCauley, MD, MPH, Howard C. Herrmann, MD, Tiffany Chen, MD, Saif Anwaruddin, MD   +3 more
doaj   +1 more source

Mitral Plasticity: The Way to Prevent the Burden of Ischemic Mitral Regurgitation?

Frontiers in Cardiovascular Medicine, 2022
The ischemic impairment of the left ventricular contractility, followed by an adverse remodeling leading to the displacement of the papillary muscles (PMs), increased tethering forces and loss of valve competence has been the long-term accepted ...
Mattia Vinciguerra, Silvia Romiti, Eleonora Wretschko, Mizar D'Abramo, David Rose, Fabio Miraldi, Ernesto Greco   +6 more
doaj   +1 more source

Ischemic Mitral Regurgitation: To Fix or Not to Fix [PDF]

Journal of Cardiothoracic and Vascular Anesthesia, 2020
Abstract Optimal interventional planning for ischemic mitral regurgitation, initially known as papillary muscle dysfunction syndrome, has been a matter of debate for decades. The primary challenge constitutes the selection of patients who will benefit from an intervention.
Huma, Fatima, Robina, Matyal, Feroze, Mahmood, Yanick, Baribeau, Kamal R, Khabbaz   +4 more
openaire   +2 more sources

Assessment of mitral valve geometric deformity in patients wi

The Egyptian Heart Journal, 2017
Background: A full understanding of the geometry of the nonplanar saddle-shaped mitral annulus can provide valuable information regarding the pathophysiology of mitral regurgitation (MR).
Maha H. El Sebaie, M.N. Abdelatti, A.A. Zarea, A.M. Farag, A.A. Hashem, A.M. Fadel   +5 more
doaj   +1 more source

Comparative results of repair of Ischemic Mitral Regurgitation (IMR): Conventional against Trans-Septal Approach

International Journal of Endorsing Health Science Research, 2017
Objective: Ischemic mitral regurgitation is common and increases mortality, even when mild. (American Heart Association) AHA and European association have both stressed the need of mitral valve repair in patients with moderate or more regurgitation.
Ahson Memon, Junaid Ansari , Ghufranullah Khan, Ali Shan, Imran Ali, Peer Asad Aziz , Hamid Ali   +6 more
doaj   +1 more source

Parameters of the mitral apparatus in patients with ischemic and nonischemic dilated cardiomyopathy

Journal of International Medical Research, 2023
The mitral valve apparatus is a complex structure consisting of several coordinating components: the annulus , two leaflets, the chordae tendineae, and the papillary muscles. Due to the intricate interplay between the mitral valve and the left ventricle,
João Presume, Mariana S Paiva, Sara Guerreiro, Regina Ribeiras   +3 more
doaj   +1 more source

Quantitative in vivo assessment of human mitral valve coaptation area after undersized ring annuloplasty repair for ischemic mitral regurgitationCentral MessagePerspective

JTCVS Techniques, 2022
Objectives: Long-term outcomes of mitral valve repair procedures to correct ischemic mitral regurgitation remain unpredictable, due to an incomplete understanding of the disease process and the inability to reliably quantify the coaptation zone using ...
Natalie T. Simonian, BS, Hao Liu, PhD, Alison M. Pouch, PhD, Joseph H. Gorman, III, MD, Robert C. Gorman, MD, Michael S. Sacks, PhD   +5 more
doaj   +1 more source

Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer, Thomas J. Stocker, Ludwig T. Weckbach, Julia Novotny, Philipp M. Doldi, Hannah Kempton, Steffen Massberg, Michael Näbauer, Jörg Hausleiter, Lukas Stolz   +9 more
wiley   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source